HIF1A and central nervous system cancer: Based on the critical role that the transcription factor HIF-1 is known to play in GBM progression and treatment resistance, we also assessed HIF-1α expression levels in the glioma cell lines at multiple time points following hypoxic conditions and reoxygenation exposures.